Recent advances in the molecular characterization of small-cell lung cancer (SCLC) have led to the identification of distinct transcriptional subtypes, defined by the differential expression of surface antigens such as SEZ6, DLL3, B7-H3 (CD276), TROP2 (TACSTD2), and CEACAM5. This evidence concerns the gene DLL3 and small cell lung carcinoma.